217 related articles for article (PubMed ID: 16804806)
21. [Switching to monotherapy and optimization of drug therapy for long-term hospitalized patients and chronically sick patients].
Hirao T
Seishin Shinkeigaku Zasshi; 2011; 113(10):1041-7. PubMed ID: 22187892
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
Wolfsperger M; Greil W; Rössler W; Grohmann R
J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
[TBL] [Abstract][Full Text] [Related]
23. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
[TBL] [Abstract][Full Text] [Related]
24. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
25. Issues in polypharmacotherapy: focus on depression in schizophrenia.
Dufresne RL
Psychopharmacol Bull; 1995; 31(4):789-96. PubMed ID: 8851655
[TBL] [Abstract][Full Text] [Related]
26. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
Strous RD; Lerner V
Am J Psychiatry; 2005 Mar; 162(3):631-2; author reply 632-3. PubMed ID: 15741496
[No Abstract] [Full Text] [Related]
27. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
28. [Is it valid to concurrently use multiple antipsychotics for patients with schizophrenia?].
Suzuki T; Watanabe K; Yagi G; Kashima H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Aug; 25(4):159-68. PubMed ID: 16190364
[TBL] [Abstract][Full Text] [Related]
29. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
[TBL] [Abstract][Full Text] [Related]
30. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
Chan J; Sweeting M
J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
[TBL] [Abstract][Full Text] [Related]
31. [Drug treatment of schizophrenic patients].
Finzen A
Schweiz Rundsch Med Prax; 1991 May; 80(22):605-9. PubMed ID: 1675808
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy of schizophrenia: ploypharmacy approaches.
Rahiminejad F; Akhondzadeh S
Acta Med Iran; 2010; 48(4):203-8. PubMed ID: 21279929
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
34. Amoxapine as an antipsychotic: comparative study versus haloperidol.
Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
[TBL] [Abstract][Full Text] [Related]
35. [Psychopharmacological combination therapy in bipolar disorder].
Quante A; van Hall F; Anghelescu I
Fortschr Neurol Psychiatr; 2009 May; 77(5):252-62. PubMed ID: 19418383
[TBL] [Abstract][Full Text] [Related]
36. Treatment-refractory bipolar disorder: classification to aid in clinical management.
Gajwani P
Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
[TBL] [Abstract][Full Text] [Related]
37. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
38. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs.
Valuck RJ; Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R;
Curr Med Res Opin; 2007 Oct; 23(10):2567-76. PubMed ID: 17848204
[TBL] [Abstract][Full Text] [Related]
39. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
Hamrin V; McDonnell MA; Moffett J; Durso S
Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]